R W Pero

2.1k total citations · 1 hit paper
42 papers, 1.7k citations indexed

About

R W Pero is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, R W Pero has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 12 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in R W Pero's work include DNA Repair Mechanisms (9 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and PARP inhibition in cancer therapy (4 papers). R W Pero is often cited by papers focused on DNA Repair Mechanisms (9 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and PARP inhibition in cancer therapy (4 papers). R W Pero collaborates with scholars based in Sweden, United States and Italy. R W Pero's co-authors include Janeric Seidegård, William R. Pearson, William R. Vorachek, D. J. Harvan, Mathilde Blois, Yuqiao Sheng, Carl Bryngelsson, Judson W. Spalding, Felix Mitelman and H. Wagner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Gut.

In The Last Decade

R W Pero

41 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion.

1988 623 citations Janeric Seidegård, R W Pero et al. profile →

Peers

R W Pero

MB

CR

PS

PHARM

ONCOL

K. V. N. Rao United States

Steven M. D’Ambrosio United States

Andrew F.G. Slater Sweden

M. Nagabhushan United States

Kamani Hemamala Tennekoon Sri Lanka

Iain G. C. Robertson New Zealand

A. Hautefeuille France

B Coles United Kingdom

James S. Felton United States

Hiroko Murakami Japan

K. V. N. Rao United States

R W Pero

609 ×0.6

MB

370 ×1.3

CR

133 ×0.5

PS

98 ×0.4

PHARM

235 ×1.2

ONCOL

Citations per year, relative to R W Pero R W Pero (= 1×) peers K. V. N. Rao

Countries citing papers authored by R W Pero

Since Specialization

Citations

This map shows the geographic impact of R W Pero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R W Pero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R W Pero more than expected).

Fields of papers citing papers by R W Pero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R W Pero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R W Pero. The network helps show where R W Pero may publish in the future.

Co-authorship network of co-authors of R W Pero

This figure shows the co-authorship network connecting the top 25 collaborators of R W Pero. A scholar is included among the top collaborators of R W Pero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R W Pero. R W Pero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Lima-de-Faria, A., et al.. (2009). Relation between ribosomal RNA genes and the DNA satellites of Phaseolus coccineus. Hereditas. 79(1). 5–19. 6 indexed citations

2.

Pero, R W, et al.. (2005). Formulation and in vitro/in vivo evaluation of combining DNA repair and immune enhancing nutritional supplements. Phytomedicine. 12(4). 255–263. 14 indexed citations

3.

Lindgren, Hanna, et al.. (2002). Mechanism of action for N-substituted benzamide-induced apoptosis. British Journal of Cancer. 86(6). 971–978. 14 indexed citations

4.

Pero, R W, et al.. (1999). N-substituted benzamides inhibit NFκB activation and induce apoptosis by separate mechanisms. British Journal of Cancer. 81(6). 981–988. 8 indexed citations

5.

Pero, R W, Ann Olsson, Carl Bryngelsson, et al.. (1998). Feasibility and quality of biological banking of human normal and tumor tissue specimens as sources of DNA for the Malmö Diet and Cancer Study.. PubMed. 7(9). 809–12. 7 indexed citations

6.

Marmor, Michael, P Alcabes, Stephen Titus, et al.. (1997). Low serum thiol levels predict shorter times-to-death among HIV-infected injecting drug users. AIDS. 11(11). 1389–1393. 27 indexed citations

7.

Kjellén, Elisabeth, R W Pero, Eva Brun, et al.. (1995). A phase I/II evaluation of metoclopramide as a radiosensitiser in patients with inoperable squamous cell carcinoma of the lung. European Journal of Cancer. 31(13-14). 2196–2202. 11 indexed citations

8.

Pero, R W, Ann Olsson, Yuqiao Sheng, et al.. (1995). Progress in identifying clinical relevance of inhibition, stimulation and measurements of poly ADP-ribosylation. Biochimie. 77(5). 385–393. 17 indexed citations

9.

Pero, R W, G Berglund, Nelwyn T. Christie, et al.. (1993). The Malmö biomarker programme. Journal of Internal Medicine. 233(1). 69–74. 1 indexed citations

10.

Pero, R W, Ann Olsson, G Berglund, et al.. (1993). The Malmö biological bank. Journal of Internal Medicine. 233(1). 63–67. 31 indexed citations

11.

Kjellén, Elisabeth, et al.. (1990). Metoclopramide enhances the effect of ionizing radiation on xenografted squamous cell carcinoma of the head and neck. International Journal of Radiation Oncology*Biology*Physics. 19(6). 1419–1424. 17 indexed citations

12.

Pero, R W, et al.. (1990). Oxidative stress, DNA repair, and cancer susceptibility.. PubMed. 14(5). 555–61. 50 indexed citations

13.

Johnson, D.B., et al.. (1989). Ornithine decarboxylase in resting human mononuclear leucocytes: Evidence for an endogenous inhibitor. International Journal of Biochemistry. 21(10). 1169–1175. 2 indexed citations

14.

Kjellén, Elisabeth, Johan Wennerberg, & R W Pero. (1989). Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck. British Journal of Cancer. 59(2). 247–250. 24 indexed citations

15.

Markowitz, Melvin M., Paul Rozen, R W Pero, Martin Tobi, & Daniel G. Miller. (1988). Hydrogen peroxide induced adenosine diphosphate ribosyl transferase (ADPRT) response in patients with inflammatory bowel disease.. Gut. 29(12). 1680–1686. 23 indexed citations

16.

Pero, R W, et al.. (1983). A genetic component of the variance of N-acetoxy-2-acetylaminofluorene-induced DNA damage in mononuclear leukocytes determined by a twin study. Human Genetics. 65(2). 181–184. 12 indexed citations

17.

Olsson, Inge, R W Pero, Tor Olofsson, & Carl Bryngelsson. (1980). N-acetoxy-2-acetylaminofluorene induced unscheduled DNA synthesis of granulopoietic precursor cells in chronic myeloid leukemia. Carcinogenesis. 1(7). 547–552. 1 indexed citations

18.

Harvan, D. J. & R W Pero. (1974). Gas chromatographic analysis of the Alternaria metabolite, tenuazonic acid. Journal of Chromatography A. 101(1). 222–224. 11 indexed citations

19.

Pero, R W, D. J. Harvan, & Mathilde Blois. (1973). Isolation of the toxin, altenuisol, from the fungus, auct.. Tetrahedron Letters. 14(12). 945–948. 66 indexed citations

20.

Pero, R W, et al.. (1973). Toxicity of metabolites produced by the "Alternaria".. Environmental Health Perspectives. 4. 87–94. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact